These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11908241)

  • 41. Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
    Miller DR
    Can J Anaesth; 2003 Mar; 50(3):215-20. PubMed ID: 12620941
    [No Abstract]   [Full Text] [Related]  

  • 42. Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?
    Nuttall GA; Malone AM; Michels CA; Trudell LC; Renk TD; Marienau ME; Oliver WC; Ackerman MJ
    Anesthesiology; 2013 Feb; 118(2):382-6. PubMed ID: 23291623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced prolongation of the QT interval: what's the point?
    White PF; Abrao J
    Anesthesiology; 2006 Feb; 104(2):386-7. PubMed ID: 16436877
    [No Abstract]   [Full Text] [Related]  

  • 44. Warnings strengthened on tranquilizer inapsine (Droperidol).
    SoRelle R
    Circulation; 2001 Dec; 104(25):E9061-2. PubMed ID: 11748130
    [No Abstract]   [Full Text] [Related]  

  • 45. You (still) can't disprove the existence of dragons.
    Scuderi PE
    Anesthesiology; 2005 Jun; 102(6):1081-2. PubMed ID: 15915016
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.
    Shale JH; Shale CM; Mastin WD
    J Clin Psychiatry; 2003 May; 64(5):500-5. PubMed ID: 12755651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New and incremental FDA black box warnings from 2008 to 2015.
    Solotke MT; Dhruva SS; Downing NS; Shah ND; Ross JS
    Expert Opin Drug Saf; 2018 Feb; 17(2):117-123. PubMed ID: 29215916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy.
    Eberhart LH; Morin AM; Hoerle S; Wulf H; Geldner G
    Ophthalmology; 2004 Aug; 111(8):1569-75. PubMed ID: 15288990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T
    Can J Gastroenterol Hepatol; 2016; 2016():2937678. PubMed ID: 27446835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
    Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
    Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Black box warnings: what do they mean to pharmacists and patients.
    Martin CM; Borgelt L
    Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A; Allan N; Wills B; Kang C; Leikin JB
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes to Norvir labeling.
    AIDS Patient Care STDS; 2008 Oct; 22(10):834-5. PubMed ID: 18924248
    [No Abstract]   [Full Text] [Related]  

  • 54. Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense.
    Viscusi WK; Rowland SR; Dorfman HL; Walsh CJ
    Spec Law Dig Health Care Law; 1996 Mar; (205):9-52. PubMed ID: 10156421
    [No Abstract]   [Full Text] [Related]  

  • 55. How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications.
    Ehrenpreis ED; Ciociola AA; Kulkarni PM;
    Am J Gastroenterol; 2012 Apr; 107(4):501-4. PubMed ID: 22475958
    [No Abstract]   [Full Text] [Related]  

  • 56. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Mar; 271(11):812. PubMed ID: 8114223
    [No Abstract]   [Full Text] [Related]  

  • 57. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
    [No Abstract]   [Full Text] [Related]  

  • 58. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FDA aluminum rule poses challenges for industry, pharmacists.
    Young D
    Am J Health Syst Pharm; 2004 Apr; 61(8):742, 744. PubMed ID: 15127953
    [No Abstract]   [Full Text] [Related]  

  • 60. Droperidol use in the emergency department is not safe.
    Prosser RL
    Acad Emerg Med; 2006 May; 13(5):585-6; author reply 586-7. PubMed ID: 16641482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.